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First Synthesis of 4-Substituted Benzenesuifonylcyanoguanidines 
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Abstract:  N'-substituted-N-cyano-S-methylcarbamimidothioates react with 4-substitutedbenzene 
sulfonamides togive the corresponding sulfonyleyanoguanidines. 
Copyright © 1996 Elsevier Science Ltd 
The cyanoguanidine group is regarded as a non-classical bioisostere of the urea and thiourea function l.
This concept has been developed for the gastric antisecretory N'-aikyI-N-imidazolylalkylthioureas to give 
cimetidine2. Conversly, N'-alkyI-N-substituted pyridyl-thioureas nd -ureas were found to be as active as 
pinacidil, an antihypertensive cyanoguanidine3,4. In the present study, we have applied this strategy to 
hypoglycemic sulfonylureas to obtain original drugs bearing a new moiety: the sulfonylcyanoguanidine 
function. 
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Scheme 1 Reagents : i, Y-NH 2 (1.5 equiv), ethanol, 25°C; ii, NaOH (1 equiv), DMF, dioxane, reflux. 
The N"[4-(substitutedphenyi)sulfonyl]-N'-substituted-N"cyanoguanidines 5-20 (table 1) were prepared 
by refluxing an excess (1.2 equiv) of N'-substituted-N-cyano-S-methylcarbamimidothioate 2 with the sodium 
salt of 4-methylbenzenesulfonamide 35 or the 4-substitutedcarboxamidoethylbenzenesulfonamide 46 (scheme 
1). The carbamimidothioates 2 were synthesized by stirring a mixture of N-cyano-S,S'-dimethylimino 
carbonate 17 in ethanol with the required amine (Y-NH2, 1.5 equiv). 
The compounds 7, 8, 12 and 13 are the bioisosteres of tolbutamide, tolcyclamide, tolazamide and 
gliclazide, the main representatives of the hypoglycemic drugs of first chemical generation (X = CH3)8. The 
antidiabetic sulfonylureas bearing a substituted carboxamidoethyl side-chain belong to the second chemical 
generation. Compound 16 is the bioisostere ofglibenclamide, one of the most potent hypoglycemic drugS. The 
electron-withdrawing groups (SO2 and =N-CN) should maintain the acidity of the moiety as compared to the 
sulfonylurea function. The IH-NMR spectra9 of 7 (8 = 5.6, 2H, br s) and 16 (~i = 4.7, 2H, br s) revealed that 
both protons of the cyanoguanidine moiety were not distinguishable and located with the residual water 
contained in DMSO-d 6. On the contrary, tolbutamide (8= 10.41, 1H, br s; 6.30, 1H, br t) and glibenclamide (~
= 10.27, 1H, br s; 6.25 IH, br d), their sulfonylurea counterparts, clearly exhibited three different signals 
corresponding to the two urea protons and residual water. These data suggest automeric forms of the 
sulfonylcyanoguanidine moiety and a higher lability of their acidic proton as compared to their sufonylurea 
bioisosteres. The chemical shift values lead to the proposal that 7 is probably more acidic than 16, as it is 
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reported for tolbutamide (pKa = 5.3)10 compared to glibenclamide (pKa = 6.8)11. All compounds were 
characterized by analytical and spectral methods9. 
Table I : Synthesis of 4-substitutedbenzenesulfonylcyanoguanidines 
sCN 
N 
X - ~  SO2NH- ICI-NH-Y 
iV' X Y Yield (%) Mp (°C)a 
5 CH 3 C2H 5 17 131-133 
6 CH 3 (CH3)2CH 72 132-134 
7 CH 3 CH3(CH2) 3 28 108-110 
8 CH 3 eyclohexyl 79 156-158 
9 CH 3 eyeloheptyl 78 144-146 
1 0 CH 3 (+)4-CH3cyelohexyl 52 163-165 
1 1 CH 3 (CH2)5N 14 210-212 
1 2 CH 3 (CH2)6N 22 193-195 
1 3 CH 3 I -azabieyelo[3,2,1 ]octane 19 186-188 
1 4 C6HsCONHCH2CH 2 cyclohexyl 76 174-176 
1 5 4-CH3OC6H4CONHCH2CH 2 cyelohexyl 26 176-178 
1 6 2-CH30,5-CIC6H3CONHCH2CH  cyclobexyl 50 92-95 
1 7 2-CH30,5-CIC6H3CONHCH2CH  (+)4-CH3cyciohexyl 64 85-87 
1 8 2-furfurylCONHCH2CH 2 cyelohexyl 55 146-148 
1 9 C6H5N'HCONHCH2CH2 eyelohexyl 37 ! 08-110 
2 0 4-CIC6H4NHCONHCH2CH 2 eyelobexyl 82 128-130 
a All compounds were crystallized from ethanol. 
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